By the same authors

From the same journal

Benefits and harms of direct to consumer advertising: a systematic review

Research output: Contribution to journalLiterature review

Published copy (DOI)

Author(s)

Department/unit(s)

Publication details

JournalQuality & Safety in Health Care
DatePublished - Aug 2005
Issue number4
Volume14
Number of pages5
Pages (from-to)246-250
Original languageEnglish

Abstract

Background: Direct to consumer advertising is increasingly used by the pharmaceutical industry, but its benefits and harms have yet to be summarised in a comprehensive and rigorous manner.

Methods: A systematic review was conducted of robust evaluations of the impact ( positive and negative) of direct to consumer advertising. A broad range of databases and data sources ( including Cinahl, Embase, HMIC, HSRProj, Medline, PsycInfo, and the internet) were searched from inception to 2004.

Results: From 2853 citations only four reports were found that met the strict inclusion criteria and provided usable results. Direct to consumer advertising is associated with increased prescription of advertised products and there is substantial impact on patients' request for specific drugs and physicians' confidence in prescribing. No additional benefits in terms of health outcomes were demonstrated.

Discussion: Direct to consumer advertising is banned in most countries, and the research evidence tends to support the negative impact that is feared by those who support a legislative ban. Further research is needed into the clinical and economic impact of direct to consumer advertising in healthcare systems.

    Research areas

  • NORMAL HUMAN-EXPERIENCE, PRESCRIPTION DRUGS, PRIMARY-CARE, PROMOTION, DISEASE

Discover related content

Find related publications, people, projects, datasets and more using interactive charts.

View graph of relations